[Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines]
Guideline
OA: closed
CC0
AI-generated summary
This review examines the non-contraceptive benefits of hormonal and non-hormonal contraceptives for women's health.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Hormonal and intrauterine contraceptive methods provide women with highly efficient protection against undesired pregnancy. Additional non-contraceptive effects are now well documented. Combined hormonal contraceptives use, either through the oral transdermal and vaginal route, allow a reduction in menorrhagia, dysmenorrhea, functional ovarian cysts, benign breast and uterine disease, endometriosis-related pain and recurrence. A reduction in ovarian cancer risks, including in women with BRCA syndrome, endometrial and colon cancer is documented. This effect is prolonged for years after contraception discontinuation. Non-contraceptive benefits of progestin-only contraceptives are less documented. Use of the levonorgestrel IUD is associated with a reduction in menorrhagia, dysmenorrhea including in case of endometriosis. Copper IUD use is associated with a decrease in cervix and endometrial cancer risk.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (32)
- Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers via openalex
- Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review via openalex
- Levonorgestrel intrauterine system versus medical therapy for menorrhagia via openalex
- Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis via openalex
- Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial via openalex
- Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills via openalex
- W2041735629 via openalex
- W2044509639 via openalex
- W2046151717 via openalex
- W2065118869 via openalex
- W2093624143 via openalex
- W2102299243 via openalex
- W2116297033 via openalex
- W2119560204 via openalex
- W2137052755 via openalex
- W2149175125 via openalex
- W2151846340 via openalex
- W2163315477 via openalex
- W2398610268 via openalex
- W2461162892 via openalex
- W2745091579 via openalex
- W2747489820 via openalex
- W2770246480 via openalex
- W2904353789 via openalex
- W4238159461 via openalex
- doi:10.1097/aog.0b013e3182118ac3 via openalex
- W6607582617 via openalex
- W1521030336 via openalex
- W1708141466 via openalex
- W1968456293 via openalex
- W1978438749 via openalex
- W2010417484 via openalex
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:23:18.497579+00:00
License: CC0
· commercial use OK